PTAB affirms validity of three Medtronic patents in Axonics suit
23-09-2021
Biotechnology company Capricor Therapeutics has agreed to acquire patents from medical equipment maker Medtronic as part of plans to develop a programme to treat heart failure.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
patents, Capricor Therapeutics, Medtronic, biotechnology
